Jiameng Chen

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Metabolic Syndrome and In-Hospital Mortality in Sepsis: A Multicenter Cohort Study Revealing a Severity-Dependent Survival Advantage Driven by Overweight and Hyperlipidemia.

Metabolic Syndrome and In-Hospital Mortality in Sepsis: A Multicenter Cohort Study Revealing a Severity-Dependent Survival Advantage Driven by Overweight and Hyperlipidemia.

Journal: Shock (Augusta, Ga.)

Published: July 20, 2026

Inhibition of ferroptosis or NF-κB signalling protects LPS-induced TIMP1 overexpression-induced cell damage.

Inhibition of ferroptosis or NF-κB signalling protects LPS-induced TIMP1 overexpression-induced cell damage.

Journal: Cellular signalling

Published: March 23, 2026

FNDC4 modulates macrophage responses and suppresses NF-κB in sepsis-induced lung injury.

FNDC4 modulates macrophage responses and suppresses NF-κB in sepsis-induced lung injury.

Journal: Molecular immunology

Published: January 04, 2026

Metabolic phenotyping of sepsis in large multicenter cohorts: identification of a reproducible high-risk subgroup.

Metabolic phenotyping of sepsis in large multicenter cohorts: identification of a reproducible high-risk subgroup.

Journal: Lipids in health and disease

Published: December 19, 2025

IFI27-mediated regulation of regulatory T cells aggravates lung injury in sepsis via IL-10/STAT3 signaling.

IFI27-mediated regulation of regulatory T cells aggravates lung injury in sepsis via IL-10/STAT3 signaling.

Journal: Frontiers in immunology

Published: December 04, 2025

HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro.

HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro.

Journal: The international journal of biochemistry & cell biology

Published: April 01, 2020

Tetramethylpyrazine alleviates LPS-induced inflammatory injury in HUVECs by inhibiting Rho/ROCK pathway.

Tetramethylpyrazine alleviates LPS-induced inflammatory injury in HUVECs by inhibiting Rho/ROCK pathway.

Journal: Biochemical and biophysical research communications

Published: April 01, 2019

Simvastatin Ameliorates PAK4 Inhibitor-Induced Gut and Lung Injury.

Simvastatin Ameliorates PAK4 Inhibitor-Induced Gut and Lung Injury.

Journal: BioMed research international

Published: July 30, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026